Cannabinoids: Emerging sleep modulator
Authors:
- Zhen Xuen Brandon LowZLZhen Xuen Brandon Low
- Xin Ru LeeXLXin Ru Lee
- Tomoko SogaTSTomoko Soga
- Bey Hing GohBGBey Hing Goh
- Deepa AlexDADeepa Alex
- Yatinesh KumariYKYatinesh Kumari
Open Access
- 3 July 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 165
Abstract
No abstract availableKeywords
Funding Information
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia (SCH-BRIMS/2020/004)
- Monash University Malaysia
This publication has 178 references indexed in Scilit:
- Does Cannabidiol Protect Against Adverse Psychological Effects of THC?Frontiers in Psychiatry, 2013
- Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in ratsPharmacological Research, 2011
- Sleep State SwitchingNeuron, 2010
- Reassessment of the structural basis of the ascending arousal systemJournal of Comparative Neurology, 2010
- CB2 cannabinoid receptor targets mitogenic Gi protein–cyclin D1 axis in osteoblastsJournal of Bone and Mineral Research, 2010
- REM, not incubation, improves creativity by priming associative networksProceedings of the National Academy of Sciences, 2009
- Beta-caryophyllene is a dietary cannabinoidProceedings of the National Academy of Sciences, 2008
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differencesBritish Journal of Pharmacology, 2007
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1and CB2receptor agonistsin vitroBritish Journal of Pharmacology, 2007